Andexanet for Factor Xa Inhibitor–Associated Acute...

Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage

Abstract

To the Editor: In the ANNEXA-I trial (Trial of Andexanet Alfa in Intracranial Hemorrhage Patients Receiving an Oral FXa Inhibitor) conducted by Connolly et al. (May 16/23 issue),1 investigators eva...

Authors

Kreutziger J; Ulmer H; Fries D

Journal

The New England Journal of Medicine, Vol. 391, No. 8, pp. 772–774

Publisher

Massachusetts Medical Society

Publication Date

August 22, 2024

DOI

10.1056/nejmc2407378

ISSN

0028-4793

Associated Experts

Ashkan Shoamanesh

Associate Professor, FHSMED

Visit profile

Mukul Sharma

Professor, FHSMED